Published in Cancer Weekly, April 17th, 2012
"Today's 'Initial Recommendation' announcement from pCODR is good news for melanoma patients in Canada," said Christine Jackson, Executive Director of the Canadian Skin Patient Alliance (CSPA). "We are pleased that pCODR is moving quickly to evaluate these drugs and we hope that the remaining...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.